
Reset all filters
01 3Tazverik
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 14
2021 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 41
2022 Revenue in Millions : 14
Growth (%) : 100
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 48
2023 Revenue in Millions : 41
Growth (%) : 19